ENSG00000173821 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000173821 0.55 4.37e-13 KIRC
ENSG00000173821 0.78 2.67e-21 BRCA
ENSG00000173821 1.13 7.38e-17 KIRP
ENSG00000173821 0.80 3.65e-14 LIHC
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000173821 head and neck tumors 26395002
ENSG00000173821 tumour 27323329
ENSG00000173821 cancer 28324520
ENSG00000173821 gastric cancer 28744403
ENSG00000173821 tumor 29755661
ENSG00000173821 metastatic tumors 30703342
ENSG00000173821 tumors 31263894
ENSG00000173821 cancers 31953610
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000173821 Merkel cell skin cancer sequence_alteration 10.0% (3/30) 1 entry
ENSG00000173821 colorectal adenocarcinoma stop_gained 10.27% (137/1334) 2 entries
ENSG00000173821 cecum adenocarcinoma missense_variant 6.061% (8/132) 1 entry
ENSG00000173821 gastric adenocarcinoma sequence_alteration 4.86% (33/679) 1 entry
ENSG00000173821 pancreatic ductal adenocarcinoma missense_variant 3.892% (49/1259) 2 entries
ENSG00000173821 esophageal adenocarcinoma sequence_alteration 7.306% (32/438) 1 entry
ENSG00000173821 skin melanoma sequence_alteration 3.922% (38/969) 2 entries
ENSG00000173821 gastric intestinal type adenocarcinoma frameshift_variant 8.235% (7/85) 1 entry
ENSG00000173821 diffuse gastric adenocarcinoma sequence_alteration 5.063% (4/79) 1 entry
ENSG00000173821 colon adenocarcinoma missense_variant 6.389% (49/767) 8 entries
ENSG00000173821 lung adenocarcinoma sequence_alteration 3.268% (40/1224) 1 entry
ENSG00000173821 breast carcinoma missense_variant 2.268% (32/1411) 2 entries
ENSG00000173821 gastric adenocarcinoma missense_variant 4.86% (33/679) 3 entries
ENSG00000173821 clear cell renal carcinoma missense_variant 1.394% (18/1291) 3 entries
ENSG00000173821 brain glioblastoma sequence_alteration 0.9709% (9/927) 2 entries
ENSG00000173821 skin melanoma missense_variant 3.922% (38/969) 4 entries
ENSG00000173821 colon adenocarcinoma sequence_alteration 6.389% (49/767) 4 entries
ENSG00000173821 hemangioblastoma sequence_alteration 15.62% (5/32) 1 entry
ENSG00000173821 brain glioblastoma missense_variant 0.9709% (9/927) 2 entries
ENSG00000173821 basal cell carcinoma missense_variant 6.897% (4/58) 1 entry
ENSG00000173821 prostate adenocarcinoma missense_variant 6.396% (93/1454) 1 entry
ENSG00000173821 rectal adenocarcinoma missense_variant 3.524% (8/227) 1 entry
ENSG00000173821 esophageal squamous cell carcinoma sequence_alteration 3.976% (27/679) 1 entry
ENSG00000173821 colorectal adenocarcinoma missense_variant 10.27% (137/1334) 5 entries
ENSG00000173821 colorectal adenocarcinoma conservative_inframe_deletion 10.27% (137/1334) 1 entry
ENSG00000173821 hepatocellular carcinoma missense_variant 3.315% (30/905) 2 entries
ENSG00000173821 acute myeloid leukemia missense_variant 0.9891% (10/1011) 2 entries
ENSG00000173821 melanoma sequence_alteration 9.804% (10/102) 2 entries
ENSG00000173821 colorectal adenocarcinoma sequence_alteration 10.27% (137/1334) 1 entry
ENSG00000173821 Cervical Small Cell Carcinoma missense_variant 33.33% (2/6) 1 entry
ENSG00000173821 melanoma missense_variant 9.804% (10/102) 2 entries
ENSG00000173821 Ampulla of Vater Carcinoma missense_variant 4.706% (4/85) 1 entry
ENSG00000173821 diffuse large B-cell lymphoma missense_variant 2.295% (7/305) 4 entries
ENSG00000173821 ovarian serous adenocarcinoma missense_variant 2.08% (14/673) 2 entries
ENSG00000173821 small cell lung carcinoma missense_variant 2.477% (8/323) 3 entries
ENSG00000173821 diffuse gastric adenocarcinoma missense_variant 5.063% (4/79) 2 entries
ENSG00000173821 oral squamous cell carcinoma missense_variant 4.265% (9/211) 4 entries
ENSG00000173821 prostate carcinoma missense_variant 3.696% (18/487) 4 entries
ENSG00000173821 squamous cell lung carcinoma sequence_alteration 3.684% (34/923) 2 entries
ENSG00000173821 prostate carcinoma sequence_alteration 3.696% (18/487) 1 entry
ENSG00000173821 osteosarcoma sequence_alteration 1.695% (2/118) 1 entry
ENSG00000173821 esophageal squamous cell carcinoma missense_variant 3.976% (27/679) 6 entries
ENSG00000173821 squamous cell lung carcinoma stop_gained 3.684% (34/923) 1 entry
ENSG00000173821 female breast carcinoma missense_variant 1.79% (7/391) 3 entries
ENSG00000173821 female breast carcinoma sequence_alteration 1.79% (7/391) 1 entry
ENSG00000173821 nasopharyngeal squamous cell carcinoma missense_variant 1.796% (3/167) 1 entry
ENSG00000173821 non-small cell lung carcinoma missense_variant 8.065% (5/62) 3 entries
ENSG00000173821 colon adenocarcinoma frameshift_variant 6.389% (49/767) 2 entries
ENSG00000173821 skin melanoma stop_gained 3.922% (38/969) 2 entries
ENSG00000173821 pancreatic ductal adenocarcinoma frameshift_variant 3.892% (49/1259) 1 entry
ENSG00000173821 bladder transitional cell carcinoma missense_variant 2.92% (4/137) 3 entries
ENSG00000173821 breast carcinoma sequence_alteration 2.268% (32/1411) 1 entry
ENSG00000173821 colorectal adenocarcinoma frameshift_variant 10.27% (137/1334) 3 entries
ENSG00000173821 breast ductal adenocarcinoma missense_variant 11.81% (71/601) 2 entries
ENSG00000173821 prostate adenocarcinoma sequence_alteration 6.396% (93/1454) 2 entries
ENSG00000173821 squamous cell lung carcinoma missense_variant 3.684% (34/923) 3 entries
ENSG00000173821 lung adenocarcinoma missense_variant 3.268% (40/1224) 5 entries
ENSG00000173821 chronic lymphocytic leukemia sequence_alteration 0.6757% (6/888) 1 entry
ENSG00000173821 gastric intestinal type adenocarcinoma missense_variant 8.235% (7/85) 2 entries
ENSG00000173821 HER2 Positive Breast Carcinoma missense_variant 7.692% (14/182) 2 entries
ENSG00000173821 lung adenocarcinoma stop_gained 3.268% (40/1224) 1 entry
ENSG00000173821 small cell lung carcinoma stop_gained 2.477% (8/323) 1 entry
ENSG00000173821 bladder transitional cell carcinoma sequence_alteration 2.92% (4/137) 1 entry
ENSG00000173821 esophageal adenocarcinoma conservative_inframe_deletion 7.306% (32/438) 1 entry
ENSG00000173821 angioimmunoblastic T-cell lymphoma sequence_alteration 1.075% (1/93) 1 entry
ENSG00000173821 angiosarcoma sequence_alteration 7.143% (1/14) 1 entry
ENSG00000173821 prostate carcinoma frameshift_variant 3.696% (18/487) 1 entry
ENSG00000173821 adrenal cortex carcinoma missense_variant 0.6098% (1/164) 1 entry
ENSG00000173821 Breast Diffuse Large B-Cell Lymphoma missense_variant 100.0% (1/1) 1 entry
ENSG00000173821 bile duct adenocarcinoma missense_variant 0.5291% (1/189) 1 entry
ENSG00000173821 Ampulla of Vater Carcinoma stop_gained 4.706% (4/85) 1 entry
ENSG00000173821 head and neck squamous cell carcinoma missense_variant 0.3195% (2/626) 1 entry
ENSG00000173821 esophageal adenocarcinoma missense_variant 7.306% (32/438) 1 entry
ENSG00000173821 Pleural Mesothelioma missense_variant 1.031% (1/97) 1 entry
ENSG00000173821 rectal adenocarcinoma stop_gained 3.524% (8/227) 1 entry
ENSG00000173821 Uterine Carcinosarcoma missense_variant 6.364% (7/110) 1 entry
ENSG00000173821 hemangioblastoma missense_variant 15.62% (5/32) 1 entry
ENSG00000173821 laryngeal squamous cell carcinoma missense_variant 3.846% (1/26) 1 entry
ENSG00000173821 embryonal rhabdomyosarcoma sequence_alteration 1.266% (1/79) 1 entry
ENSG00000173821 Pleural Sarcomatoid Mesothelioma missense_variant 16.67% (1/6) 1 entry
ENSG00000173821 Spinal Cord Astrocytoma missense_variant 25.0% (1/4) 1 entry
ENSG00000173821 HER2 Positive Breast Carcinoma frameshift_variant 7.692% (14/182) 1 entry
ENSG00000173821 non-small cell lung carcinoma stop_gained 8.065% (5/62) 1 entry
ENSG00000173821 Adamantinomatous Craniopharyngioma missense_variant 8.333% (1/12) 1 entry
ENSG00000173821 Gallbladder Adenocarcinoma sequence_alteration 2.299% (2/87) 1 entry
ENSG00000173821 Pleural Epithelioid Mesothelioma missense_variant 1.064% (1/94) 1 entry
ENSG00000173821 hepatocellular carcinoma frameshift_variant 3.315% (30/905) 1 entry
ENSG00000173821 T-cell acute lymphoblastic leukemia stop_gained 0.2632% (1/380) 1 entry
ENSG00000173821 Merkel cell skin cancer missense_variant 10.0% (3/30) 1 entry
ENSG00000173821 esophageal squamous cell carcinoma stop_gained 3.976% (27/679) 1 entry
ENSG00000173821 medullary thyroid gland carcinoma missense_variant 5.263% (1/19) 1 entry
ENSG00000173821 ovarian serous adenocarcinoma frameshift_variant 2.08% (14/673) 1 entry
ENSG00000173821 acute lymphoblastic leukemia missense_variant 0.3115% (1/321) 1 entry
ENSG00000173821 lung carcinoid tumor sequence_alteration 18.18% (2/11) 1 entry
ENSG00000173821 squamous cell lung carcinoma frameshift_variant 3.684% (34/923) 1 entry
ENSG00000173821 pseudomyxoma peritonei missense_variant 10.0% (1/10) 1 entry
ENSG00000173821 multiple myeloma stop_gained 2.273% (1/44) 1 entry
ENSG00000173821 large cell lung carcinoma missense_variant 5.556% (1/18) 1 entry
ENSG00000173821 oral squamous cell carcinoma frameshift_variant 4.265% (9/211) 1 entry
ENSG00000173821 alveolar rhabdomyosarcoma missense_variant 1.695% (1/59) 1 entry
ENSG00000173821 mucosal melanoma sequence_alteration 7.143% (1/14) 1 entry
ENSG00000173821 basal cell carcinoma sequence_alteration 6.897% (4/58) 1 entry
ENSG00000173821 anaplastic astrocytoma missense_variant 2.174% (1/46) 1 entry
ENSG00000173821 brain glioblastoma frameshift_variant 0.9709% (9/927) 1 entry
ENSG00000173821 lung carcinoid tumor missense_variant 18.18% (2/11) 1 entry
ENSG00000173821 small cell lung carcinoma sequence_alteration 2.477% (8/323) 1 entry
ENSG00000173821 lung adenocarcinoma frameshift_variant 3.268% (40/1224) 1 entry
ENSG00000173821 breast ductal adenocarcinoma stop_gained 11.81% (71/601) 1 entry
ENSG00000173821 metaplastic breast carcinoma missense_variant 1.961% (1/51) 1 entry
ENSG00000173821 Gallbladder Adenocarcinoma missense_variant 2.299% (2/87) 1 entry
ENSG00000173821 Spinal Cord Astrocytoma sequence_alteration 25.0% (1/4) 1 entry
ENSG00000173821 multiple myeloma missense_variant 2.273% (1/44) 1 entry
ENSG00000173821 Ampulla of Vater Carcinoma conservative_inframe_deletion 4.706% (4/85) 1 entry
ENSG00000173821 female breast carcinoma frameshift_variant 1.79% (7/391) 1 entry
ENSG00000173821 esophageal squamous cell carcinoma frameshift_variant 3.976% (27/679) 1 entry
ENSG00000173821 head and neck squamous cell carcinoma frameshift_variant 0.3195% (2/626) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000173821 MESO 0.017 low
ENSG00000173821 SARC 0.0042 low
ENSG00000173821 STAD 0.014 low
ENSG00000173821 CHOL 0.011 low
ENSG00000173821 PAAD 0.017 high
ENSG00000173821 UCEC 0.00017 high
ENSG00000173821 HNSC 0.039 low
ENSG00000173821 READ 0.0018 low
ENSG00000173821 KICH 0.011 high
ENSG00000173821 PCPG 0.033 low
ENSG00000173821 BRCA 0.046 high
ENSG00000173821 DLBC 0.036 high
ENSG00000173821 TGCT 0.0042 low
ENSG00000173821 BLCA 0.04 low
ENSG00000173821 LAML 0.029 high
ENSG00000173821 LIHC 0.012 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000173821 LUSC Amp 1.142379 0.209089 0.447768 0.441118
ENSG00000173821 LUAD Amp 3.076983 0.170717 0.401719 0.505814
ENSG00000173821 LGG Amp 2.097083 0.064295 0.482847 0.091618
ENSG00000173821 CESC Amp 0.621697 0.124506 0.535328 0.223729
ENSG00000173821 CESC Del 1.635624 0.085144 0.460950 0.145763
ENSG00000173821 UCS Amp 1.084949 0.557498 0.741088 0.535714
ENSG00000173821 PAAD Del 2.986510 0.085906 0.345252 0.217391
ENSG00000173821 SKCM Amp 5.715045 0.259739 0.577725 0.332425
ENSG00000173821 LIHC Amp 10.460164 0.295266 0.688806 0.383784
ENSG00000173821 BLCA Amp 1.749736 0.201579 0.454823 0.473039
ENSG00000173821 BRCA Amp 19.755569 0.347583 0.622851 0.362037
ENSG00000173821 UCEC Amp 3.457937 0.158430 0.569854 0.166976
ENSG00000173821 UVM Amp 0.815688 0.175682 0.773563 0.175000
ENSG00000173821 OV Amp 3.327180 0.411503 0.553535 0.369603